Research programme: cell therapies - Regulus Therapeutics
Latest Information Update: 12 Jan 2022
At a glance
- Originator Regulus Therapeutics
- Class Cell therapies
- Mechanism of Action Cell replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Unspecified
Most Recent Events
- 31 Dec 2021 Early research in Unspecified in USA (Parenteral)